Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy

Capturing high-quality data from adult and elderly patients in multinational trials is no easy task—but it’s possible. In a Phase III idiopathic pulmonary fibrosis (IPF) study spanning 1,125 patients across 350 sites in 34 countries, a leading pharmaceutical company partnered with Signant Health to overcome this challenge.

Using provisioned smartphones with an intuitive eCOA design tailored for older adults, the study achieved seamless patient engagement, real-time site monitoring, and full regulatory traceability. Built-in reminders, multilingual support, and comprehensive onboarding ensured adherence, while dashboards gave sites actionable insights to minimize missing data. This innovative approach transformed traditional paper-based assessments into reliable, audit-ready digital data, even across a complex multinational landscape.

Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Download the full case study to explore implementation strategies, lessons learned, and measurable results.